Chris is a co-founder and Managing Director of Ackerley Partners, LLC, a private investment company focused on the media and entertainment sectors. Prior to founding Ackerley Partners in 2002, Chris was the President of The Ackerley Group, Inc. (NYSE: AK) where he oversaw the daily operations of the national media and entertainment company. Mr. Ackerley successfully led the merger of The Ackerley Group, Inc. with Clear Channel Communications, Inc. (NYSE: CCU) and led the negotiations and completion of The Ackerley Group’s sale of the Seattle SuperSonics and the Seattle Storm to The Basketball Club of Seattle led by Starbucks Chairman and CEO – Howard Schultz.
Brett is a seasoned entrepreneur, investor and business executive possessing extensive experience in both the private and corporate arenas. With nearly two decades leading companies in the healthcare information and services industry, he has brought to market new ways to help healthcare organizations succeed and thrive in a dramatically changing marketplace. Brett has built his career on the development and delivery of innovative solutions for hospitals and other healthcare-focused organizations—all for the purposes of reducing costs, increasing productivity and enhancing the quality of patient care. His market insights have been honed by close collaboration with senior executives at many of the world’s most respected medical institutions and leading healthcare technology innovators.
In 1977, Woody Howse and Thomas Cable formed Cable & Howse Ventures, an early stage venture capital firm focused on technology. This company managed five venture capital partnerships with an aggregate capitalization of $160 million and invested in 103 companies. In 1982, Woody also participated in the founding of Cable, Howse and Ragen, investment banking and stock brokerage firm. Woody has served as a corporate director and advisor to various public, private and non-profit enterprises. He served on the board of the National Venture Capital Association and is past President of the Stanford Business School Alumni Association. He currently serves on the boards of directors for Capstone Therapeutics, Inc (OTCQB:CAPS) and Formotus, Inc.